Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Untreated congenital adrenal hyperplasia can lead to complications like stroke and needs glucocorticoid treatment.

Finasteride's sexual side effects may be due to nocebo effect.

Monitoring for adverse effects in clinical treatments is crucial.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

A woman's diabetes improved after removing ovarian tumors that caused high testosterone levels.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Hair loss can occur when stomach cancer spreads to the scalp.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.